Lv52
890 积分 2025-09-11 加入
路漫漫其修远兮，吾将上下而求索。
Is the steady-state concentration, duration of action, or molecular weight of GLP-1RA associated with cardiovascular and renal outcomes in type 2 diabetes?
3小时前
已完结
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
4天前
已完结
Comparation of fixed‐ratio (IDegLira and iGlarLixi) versus free combination of basal insulin and glucagon‐like peptide‐1 receptor agonist for uncontrolled type 2 diabetes: A systematic review and network meta‐analysis
6天前
已完结
Incretin-Based Dual and Triple Agonists in Overweight or Obese Individuals: A Systematic Review and Meta-Analysis
6天前
已完结
Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes
6天前
已完结
Effect of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: An Exploratory Metabolomics and Validation Study
13天前
已完结
Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in China
14天前
已完结
Weight management treatment in obesity
17天前
已完结
Clinical management and treatment of obesity in China
17天前
已完结
Endoscopic Sleeve Gastroplasty Reduces Atherosclerotic Cardiovascular Disease Risk: A Cohort Study Using Pooled Cohort Equations and Predicting Risk of Cardiovascular Disease Events Models
18天前
已关闭
皖公网安备34019202002308
